...
首页> 外文期刊>British Journal of Haematology >How we manage haemostasis during sepsis
【24h】

How we manage haemostasis during sepsis

机译:我们如何在败血症期间管理血赦

获取原文
获取原文并翻译 | 示例

摘要

Summary Sepsis may be associated with activation of the coagulation system and, in its most severe form, may result in disseminated intravascular coagulation ( DIC ). Initially, there is thrombosis primarily affecting small and medium sized vessels and contributing to organ dysfunction, but continued activation results in consumption of coagulation factors. This results in prolongation of global coagulation parameters. Often thrombocytopenia is the initial feature in sepsis, which may be followed by prolongation of global coagulation assays, and in severe cases, associated with hypofibrinogenaemia, with overactivation of the fibrinolytic path. The end result is a bleeding phenotype. Scoring systems can be used to help identify patients at risk of DIC and aid in confirming a diagnosis of DIC utilising routine laboratory parameters. Discussion includes medical and blood product support of haemostasis, from thrombotic to bleeding states, in relation to sepsis trigger.
机译:发明内容败血症可能与凝血系统的激活相关,并且其最严重的形式可能导致弥散血管内凝血(DIC)。 最初,存在主要影响中小型和中型血管并有助于器官功能障碍,但继续激活导致凝血因子的消耗。 这导致全局凝血参数延长。 通常血小板减少症是败血症中的初始特征,其次可以随后随后延长与脱氧血症血症有关的严重病例,具有纤维蛋白溶解路径的过度活化。 最终结果是出血表型。 评分系统可用于帮助鉴定DIC风险的患者,并有助于确认利用常规实验室参数的DIC的诊断。 讨论包括肝脏的医疗和血液产品支持,与血栓触发相关的血栓形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号